GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION (Notes) | 12 Months Ended |
Dec. 31, 2012 |
Guarantor and Non-Guarantor Financial Information [Abstract] | |
Guarantor and Non-guarantor Financial Information [Text Block] | 24. GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION |
As discussed in Note 5, "Long-term Debt and Other Financing Arrangements", our 100% owned subsidiaries, Central European Media Enterprises N.V. ("CME NV") and CME Media Enterprises B.V. ("CME BV" and with CME NV, the "Guarantor Subsidiaries"), have fully and unconditionally guaranteed, jointly and severally, subject to certain limits imposed by local law (the “Guarantees”), on a senior basis the 2017 PIK Notes. The Guarantor Subsidiaries are subject to the requirements of Rule 3-10 of Regulation S-X regarding financial statements of guarantors and issuers of guaranteed securities registered or being registered with the SEC. Our remaining subsidiaries (the “Non-Guarantor Subsidiaries”) are presented separately from CME Ltd. (the “Parent Issuer”) and the Guarantor Subsidiaries in the condensed consolidating financial statements presented below. |
The Guarantees are senior obligations of the Guarantors and rank equal in right of payment with all of the Guarantor Subsidiaries’ existing and future senior indebtedness, including in respect of their guarantees of the 2015 Convertible Notes, the 2017 Term Loan and the 2017 Revolving Credit Facility. In addition, the Guarantees rank senior in right of payment to any other existing and future obligations of the Guarantor Subsidiaries expressly subordinated in right of payment to the Guarantees. The Guarantees effectively rank junior to all of the future indebtedness and other liabilities of our Non-Guarantor Subsidiaries, including with respect to their obligations in respect of the 2017 PIK Notes. |
CME Ltd. and the Guarantor Subsidiaries are holding companies with no revenue-generating operations and rely on the repayment of intercompany indebtedness and the declaration of dividends to receive distributions of cash from our operating subsidiaries and affiliates. There are no significant restrictions on CME Ltd.'s ability to obtain funds from the Guarantor Subsidiaries. |
Subsequent to the issuance of our 2013 consolidated financial statements, we determined that the investors’ share of its subsidiaries’ other comprehensive loss had been recorded within the loss from investment in subsidiaries rather than in the investors’ other comprehensive income / loss. In addition, we determined that certain of the Guarantor Subsidiaries investments in subsidiaries had been eliminated within its balance sheet rather than as a consolidating elimination. The amounts have been reclassified in our condensed consolidating statements of operations and comprehensive income for the years ended December 31, 2013 and 2012, and in our condensed consolidating balance sheets as at December 31, 2013, with no impact to our consolidated statements of operations and comprehensive income or consolidated balance sheets. |
|
The following tables present condensed consolidating financial information relating to the Guarantor Subsidiaries as at December 31, 2014 and 2013, and for the years ended December 31, 2014, 2013 and 2012: |
Condensed Consolidating Balance Sheets as at December 31, 2014 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
ASSETS | | | | | | | | | | | |
Current assets | | | | | | | | | | | |
Cash and cash equivalents | $ | 613 | | | $ | 2,931 | | | $ | 30,754 | | | $ | — | | | $ | 34,298 | | | |
| |
Accounts receivable, net | — | | | — | | | 175,866 | | | — | | | 175,866 | | | |
| |
Program rights, net | — | | | — | | | 99,358 | | | — | | | 99,358 | | | |
| |
Other current assets | 1,007 | | | 346 | | | 34,128 | | | — | | | 35,481 | | | |
| |
Assets held for sale | — | | | — | | | 29,866 | | | — | | | 29,866 | | | |
| |
Intercompany current assets | 12,582 | | | 14,333 | | | 17,492 | | | (44,407 | ) | | — | | | |
| |
Total current assets | 14,202 | | | 17,610 | | | 387,464 | | | (44,407 | ) | | 374,869 | | | |
| |
Non-current assets | | | | | | | | | | | |
Investments in subsidiaries | 110,186 | | | 1,516,707 | | | — | | | (1,626,893 | ) | | — | | | |
| |
Property, plant and equipment, net | — | | | — | | | 114,335 | | | — | | | 114,335 | | | |
| |
Program rights, net | — | | | — | | | 207,264 | | | — | | | 207,264 | | | |
| |
Goodwill | — | | | — | | | 681,398 | | | — | | | 681,398 | | | |
| |
Broadcast licenses and other intangible assets, net | — | | | — | | | 183,378 | | | — | | | 183,378 | | | |
| |
Other non-current assets | 55,471 | | | — | | | 2,645 | | | — | | | 58,116 | | | |
| |
Intercompany non-current assets | 1,252,708 | | | 32,781 | | | 291,589 | | | (1,577,078 | ) | | — | | | |
| |
Total non-current assets | 1,418,365 | | | 1,549,488 | | | 1,480,609 | | | (3,203,971 | ) | | 1,244,491 | | | |
| |
Total assets | $ | 1,432,567 | | | $ | 1,567,098 | | | $ | 1,868,073 | | | $ | (3,248,378 | ) | | $ | 1,619,360 | | | |
| |
| | |
| | | | | | | | | | | | | | | | | | | | | |
LIABILITIES AND EQUITY | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | |
Accounts payable and accrued liabilities | $ | 5,109 | | | $ | 286 | | | $ | 173,829 | | | $ | — | | | $ | 179,224 | | | |
| |
Current portion of long-term debt and other financing arrangements | 251,669 | | | — | | | 1,190 | | | — | | | 252,859 | | | |
| |
Other current liabilities | 271 | | | — | | | 7,541 | | | — | | | 7,812 | | | |
| |
Liabilities held for sale | — | | | — | | | 10,632 | | | — | | | 10,632 | | | |
| |
Intercompany current liabilities | 7,003 | | | 35,151 | | | 2,253 | | | (44,407 | ) | | — | | | |
| |
Total current liabilities | 264,052 | | | 35,437 | | | 195,445 | | | (44,407 | ) | | 450,527 | | | |
| |
Non-current liabilities | | | | | | | | | | | | | |
| |
Long-term debt and other financing arrangements | 615,698 | | | — | | | 5,542 | | | — | | | 621,240 | | | |
| |
Other non-current liabilities | 16,315 | | | 482 | | | 29,688 | | | — | | | 46,485 | | | |
| |
Intercompany non-current liabilities | 32,782 | | | 1,392,535 | | | 151,761 | | | (1,577,078 | ) | | — | | | |
| |
Total non-current liabilities | 664,795 | | | 1,393,017 | | | 186,991 | | | (1,577,078 | ) | | 667,725 | | | |
| |
Temporary equity | 223,926 | | | — | | | — | | | — | | | 223,926 | | | |
| |
Total CME Ltd. shareholders’ equity | 279,794 | | | 138,644 | | | 1,488,249 | | | (1,626,893 | ) | | 279,794 | | | |
| |
Noncontrolling interests | — | | | — | | | (2,612 | ) | | — | | | (2,612 | ) | | |
| |
Total equity | 279,794 | | | 138,644 | | | 1,485,637 | | | (1,626,893 | ) | | 277,182 | | | |
| |
Total liabilities and equity | $ | 1,432,567 | | | $ | 1,567,098 | | | $ | 1,868,073 | | | $ | (3,248,378 | ) | | $ | 1,619,360 | | | |
| |
Condensed Consolidating Balance Sheets as at December 31, 2013 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
ASSETS | | | | | | | | | | | |
Current assets | | | | | | | | | | | |
Cash and cash equivalents | $ | 19,461 | | | $ | 5,422 | | | $ | 77,439 | | | $ | — | | | $ | 102,322 | | | |
| |
Accounts receivable, net | — | | | — | | | 169,054 | | | — | | | 169,054 | | | |
| |
Program rights, net | — | | | — | | | 96,099 | | | — | | | 96,099 | | | |
| |
Other current assets | 2,638 | | | 31 | | | 40,134 | | | — | | | 42,803 | | | |
| |
Assets held for sale | — | | | — | | | 117,002 | | | — | | | 117,002 | | | |
| |
Intercompany current assets | 53,396 | | | 2,052 | | | — | | | (55,448 | ) | | — | | | |
| |
Total current assets | 75,495 | | | 7,505 | | | 499,728 | | | (55,448 | ) | | 527,280 | | | |
| |
Non-current assets | | | | | | | | | | | | | |
| |
Investments in subsidiaries | — | | | 1,447,178 | | | — | | | (1,447,178 | ) | | — | | | |
| |
Property, plant and equipment, net | — | | | — | | | 142,907 | | | — | | | 142,907 | | | |
| |
Program rights, net | — | | | — | | | 272,997 | | | — | | | 272,997 | | | |
| |
Goodwill | — | | | — | | | 782,870 | | | — | | | 782,870 | | | |
| |
Broadcast licenses and other intangible assets, net | — | | | — | | | 222,119 | | | — | | | 222,119 | | | |
| |
Other non-current assets | 3,976 | | | — | | | 9,724 | | | — | | | 13,700 | | | |
| |
Intercompany non-current assets | 1,822,966 | | | 315,017 | | | 18,887 | | | (2,156,870 | ) | | — | | | |
| |
Total non-current assets | 1,826,942 | | | 1,762,195 | | | 1,449,504 | | | (3,604,048 | ) | | 1,434,593 | | | |
| |
Total assets | $ | 1,902,437 | | | $ | 1,769,700 | | | $ | 1,949,232 | | | $ | (3,659,496 | ) | | $ | 1,961,873 | | | |
| |
| |
| | | | | | | | | | | | | | | | | | | | | |
LIABILITIES AND EQUITY | | | | | | | | | | |
Current liabilities | | | | | | | | | | |
Accounts payable and accrued liabilities | $ | 18,234 | | | $ | 41 | | | $ | 259,405 | | | $ | — | | | $ | 277,680 | | |
|
Current portion of long-term debt and other financing arrangements | — | | | 71 | | | 1,390 | | | — | | | 1,461 | | |
|
Other current liabilities | 500 | | | — | | | 13,511 | | | — | | | 14,011 | | |
|
Liabilities held for sale | — | | | — | | | 29,529 | | | — | | | 29,529 | | |
|
Intercompany current liabilities | 7,788 | | | 45,988 | | | 1,672 | | | (55,448 | ) | — | | — | | |
|
Total current liabilities | 26,522 | | | 46,100 | | | 305,507 | | | (55,448 | ) | | 322,681 | | |
|
Non-current liabilities | | | | | | | | | | | | |
|
Deficiency in excess of investments in subsidiaries | 297,244 | | | — | | | — | | | (297,244 | ) | | — | | |
|
Long-term debt and other financing arrangements | 620,375 | | | — | | | 342,427 | | | — | | | 962,802 | | |
|
Other non-current liabilities | — | | | — | | | 27,499 | | | — | | | 27,499 | | |
|
Intercompany non-current liabilities | 310,298 | | | 1,846,572 | | | — | | | (2,156,870 | ) | | — | | |
|
Total non-current liabilities | 1,227,917 | | | 1,846,572 | | | 369,926 | | | (2,454,114 | ) | | 990,301 | | |
|
Temporary equity | 207,890 | | | — | | | — | | | — | | | 207,890 | | |
|
Total CME Ltd. shareholders’ equity / (deficit) | 440,108 | | | (122,972 | ) | | 1,272,906 | | | (1,149,934 | ) | | 440,108 | | |
|
Noncontrolling interests | — | | | — | | | 893 | | | — | | | 893 | | |
|
Total equity / (deficit) | 440,108 | | | (122,972 | ) | | 1,273,799 | | | (1,149,934 | ) | | 441,001 | | |
|
Total liabilities and equity | $ | 1,902,437 | | | $ | 1,769,700 | | | $ | 1,949,232 | | | $ | (3,659,496 | ) | | $ | 1,961,873 | | |
|
Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2014 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
Net revenues | $ | — | | | $ | — | | | $ | 680,793 | | | $ | — | | | $ | 680,793 | | | |
| |
Cost of revenues | — | | | — | | | 489,041 | | | — | | | 489,041 | | | |
| |
Selling, general and administrative expenses | 19,026 | | | 804 | | | 123,786 | | | — | | | 143,616 | | | |
| |
Restructuring costs | — | | | — | | | 9,856 | | | — | | | 9,856 | | | |
| |
Operating (loss) / income | (19,026 | ) | | (804 | ) | | 58,110 | | | — | | | 38,280 | | | |
| |
Interest income | 138,020 | | | 26,198 | | | 1,668 | | | (165,592 | ) | | 294 | | | |
| |
Interest expense | (138,480 | ) | | (137,891 | ) | | (31,226 | ) | | 165,592 | | | (142,005 | ) | | |
| |
Loss on extinguishment of debt | (24,161 | ) | | — | | | (15,042 | ) | | — | | | (39,203 | ) | | |
| |
Foreign currency exchange gain / (loss), net | 3,926 | | | 2,243 | | | (18,936 | ) | | — | | | (12,767 | ) | | |
| |
Change in fair value of derivatives | 2,311 | | | (6,663 | ) | | 6,663 | | | — | | | 2,311 | | | |
| |
Other income | — | | | — | | | 267 | | | — | | | 267 | | | |
| |
(Loss) / income from continuing operations before tax and loss from investment in subsidiaries | (37,410 | ) | | (116,917 | ) | | 1,504 | | | — | | | (152,823 | ) | | |
| |
Credit / (provision) for income taxes | — | | | 12,170 | | | (10,812 | ) | | — | | | 1,358 | | | |
| |
Loss from continuing operations before loss from investment in subsidiaries | (37,410 | ) | | (104,747 | ) | | (9,308 | ) | | — | | | (151,465 | ) | | |
| |
Loss from investment in subsidiaries | (190,018 | ) | | (85,271 | ) | | — | | | 275,289 | | | — | | | |
| |
Loss from continuing operations | (227,428 | ) | | (190,018 | ) | | (9,308 | ) | | 275,289 | | | (151,465 | ) | | |
| |
Loss from discontinued operations, net of tax | — | | | — | | | (80,431 | ) | | — | | | (80,431 | ) | | |
| |
Net loss | (227,428 | ) | | (190,018 | ) | | (89,739 | ) | | 275,289 | | | (231,896 | ) | | |
| |
Net loss attributable to noncontrolling interests | — | | | — | | | 4,468 | | | — | | | 4,468 | | | |
| |
Net loss attributable to CME Ltd. | (227,428 | ) | | (190,018 | ) | | (85,271 | ) | | 275,289 | | | (227,428 | ) | | |
| |
| | | | | | | | | | | |
Net loss | $ | (227,428 | ) | | $ | (190,018 | ) | | $ | (89,739 | ) | | $ | 275,289 | | | $ | (231,896 | ) | | |
| |
Other comprehensive loss | (162,136 | ) | | (319,647 | ) | | (155,197 | ) | | 480,163 | | | (156,817 | ) | | |
| |
Comprehensive loss | (389,564 | ) | | (509,665 | ) | | (244,936 | ) | | 755,452 | | | (388,713 | ) | | |
| |
Comprehensive loss attributable to noncontrolling interests | — | | | — | | | 3,505 | | | — | | | 3,505 | | | |
| |
Comprehensive loss attributable to CME Ltd. | $ | (389,564 | ) | | $ | (509,665 | ) | | $ | (241,431 | ) | | $ | 755,452 | | | $ | (385,208 | ) | | |
| |
Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2013 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
Net revenues | $ | — | | | $ | — | | | $ | 633,134 | | | $ | — | | | $ | 633,134 | | | |
| |
Cost of revenues | — | | | — | | | 578,570 | | | — | | | 578,570 | | | |
| |
Selling, general and administrative expenses | 33,905 | | | 5 | | | 102,483 | | | — | | | 136,393 | | | |
| |
Restructuring costs | 2,422 | | | 24 | | | 16,066 | | | — | | | 18,512 | | | |
| |
Impairment charge | — | | | — | | | 79,676 | | | — | | | 79,676 | | | |
| |
Operating loss | (36,327 | ) | | (29 | ) | | (143,661 | ) | | — | | | (180,017 | ) | | |
| |
Interest income | 137,545 | | | 6,519 | | | 462 | | | (144,030 | ) | | 496 | | | |
| |
Interest expense | (88,102 | ) | | (124,100 | ) | | (43,537 | ) | | 144,030 | | | (111,709 | ) | | |
| |
Loss on extinguishment of debt | (23,115 | ) | | — | | | — | | | — | | | (23,115 | ) | | |
| |
Foreign currency exchange gain / (loss), net | 29,773 | | | 27,790 | | | (37,376 | ) | | — | | | 20,187 | | | |
| |
Change in fair value of derivatives | — | | | (18,779 | ) | | 18,883 | | | — | | | 104 | | | |
| |
Other expense | — | | | (81 | ) | | (292 | ) | | — | | | (373 | ) | | |
| |
Income / (loss) from continuing operations before tax and loss from investment in subsidiaries | 19,774 | | | (108,680 | ) | | (205,521 | ) | | — | | | (294,427 | ) | | |
| |
Credit for income taxes | — | | | 9,510 | | | 8,483 | | | — | | | 17,993 | | | |
| |
Income / (loss) from continuing operations before loss from investment in subsidiaries | 19,774 | | | (99,170 | ) | | (197,038 | ) | | — | | | (276,434 | ) | | |
| |
Loss on investment in subsidiaries | (297,425 | ) | | (198,255 | ) | | — | | | 495,680 | | | — | | | |
| |
Loss from continuing operations | (277,651 | ) | | (297,425 | ) | | (197,038 | ) | | 495,680 | | | (276,434 | ) | | |
| |
Loss from discontinued operations, net of tax | — | | | — | | | (5,099 | ) | | — | | | (5,099 | ) | | |
| |
Net loss | (277,651 | ) | | (297,425 | ) | | (202,137 | ) | | 495,680 | | | (281,533 | ) | | |
| |
Net loss attributable to noncontrolling interests | — | | | — | | | 3,882 | | | — | | | 3,882 | | | |
| |
Net loss attributable to CME Ltd. | (277,651 | ) | | (297,425 | ) | | (198,255 | ) | | 495,680 | | | (277,651 | ) | | |
| |
| | | | | | | | | | | |
Net loss | $ | (277,651 | ) | | $ | (297,425 | ) | | $ | (202,137 | ) | | $ | 495,680 | | | $ | (281,533 | ) | | |
| |
Other comprehensive loss | (56,907 | ) | | (73,313 | ) | | (4,356 | ) | | 76,376 | | | (58,200 | ) | | |
| |
Comprehensive loss | (334,558 | ) | | (370,738 | ) | | (206,493 | ) | | 572,056 | | | (339,733 | ) | | |
| |
Comprehensive loss attributable to noncontrolling interests | — | | | — | | | 4,103 | | | — | | | 4,103 | | | |
| |
Comprehensive loss attributable to CME Ltd. | $ | (334,558 | ) | | $ | (370,738 | ) | | $ | (202,390 | ) | | $ | 572,056 | | | $ | (335,630 | ) | | |
| |
Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2012 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
Net revenues | $ | — | | | $ | — | | | $ | 705,999 | | | $ | — | | | $ | 705,999 | | | |
| |
Cost of revenues | — | | | — | | | 544,819 | | | — | | | 544,819 | | | |
| |
Selling, general and administrative expenses | 19,999 | | | 1,408 | | | 103,359 | | | — | | | 124,766 | | | |
| |
Impairment charge | — | | | — | | | 516,203 | | | — | | | 516,203 | | | |
| |
Operating loss | (19,999 | ) | | (1,408 | ) | | (458,382 | ) | | — | | | (479,789 | ) | | |
| |
Interest income | 144,057 | | | 851 | | | 562 | | | (144,744 | ) | | 726 | | | |
| |
Interest expense | (96,582 | ) | | (118,530 | ) | | (57,286 | ) | | 144,744 | | | (127,654 | ) | | |
| |
Loss on extinguishment of debt | (198 | ) | | — | | | — | | | — | | | (198 | ) | | |
| |
Foreign currency exchange gain / (loss), net | 8,170 | | | (7,402 | ) | | 5,618 | | | — | | | 6,386 | | | |
| |
Change in fair value of derivatives | 48,453 | | | — | | | 574 | | | — | | | 49,027 | | | |
| |
Other income | — | | | — | | | 1,043 | | | — | | | 1,043 | | | |
| |
Income / (loss) from continuing operations before tax and loss from investment in subsidiaries | 83,901 | | | (126,489 | ) | | (507,871 | ) | | — | | | (550,459 | ) | | |
| |
Credit for income taxes | — | | | 13,657 | | | 1,094 | | | — | | | 14,751 | | | |
| |
Income / (loss) from continuing operations before loss from investment in subsidiaries | 83,901 | | | (112,832 | ) | | (506,777 | ) | | — | | | (535,708 | ) | | |
| |
Loss on investment in subsidiaries | (619,581 | ) | | (506,749 | ) | | — | | | 1,126,330 | | | — | | | |
| |
Loss from continuing operations | (535,680 | ) | | (619,581 | ) | | (506,777 | ) | | 1,126,330 | | | (535,708 | ) | | |
| |
Loss from discontinued operations, net of tax | — | | | — | | | (10,685 | ) | | — | | | (10,685 | ) | | |
| |
Net loss | (535,680 | ) | | (619,581 | ) | | (517,462 | ) | | 1,126,330 | | | (546,393 | ) | | |
| |
Net loss attributable to noncontrolling interests | — | | | — | | | 10,713 | | | — | | | 10,713 | | | |
| |
Net loss attributable to CME Ltd. | $ | (535,680 | ) | | $ | (619,581 | ) | | $ | (506,749 | ) | | $ | 1,126,330 | | | $ | (535,680 | ) | | |
| |
| | | | | | | | | | | |
Net loss | $ | (535,680 | ) | | $ | (619,581 | ) | | $ | (517,462 | ) | | $ | 1,126,330 | | | $ | (546,393 | ) | | |
| |
Other comprehensive income | 28,555 | | | 28,555 | | | 51,333 | | | (79,792 | ) | | 28,651 | | | |
| |
Comprehensive loss | (507,125 | ) | | (591,026 | ) | | (466,129 | ) | | 1,046,538 | | | (517,742 | ) | | |
| |
Comprehensive loss attributable to noncontrolling interests | — | | | — | | | 10,617 | | | — | | | 10,617 | | | |
| |
Comprehensive loss attributable to CME Ltd. | $ | (507,125 | ) | | $ | (591,026 | ) | | $ | (455,512 | ) | | $ | 1,046,538 | | | $ | (507,125 | ) | | |
| |
Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2014 | | |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | | | |
| |
Net cash generated from / (used in) operating activities | $ | 67,171 | | | $ | (132,570 | ) | | $ | 157 | | | $ | — | | | $ | (65,242 | ) | | |
| |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | |
Purchase of property, plant and equipment | — | | | — | | | (28,685 | ) | | — | | | (28,685 | ) | | |
| |
Disposal of property, plant and equipment | — | | | — | | | 137 | | | — | | | 137 | | | |
| |
Intercompany investing receipts | 703,941 | | | 356,217 | | | — | | | (1,060,158 | ) | | — | | | |
| |
Intercompany investing payments | (900,009 | ) | | (418,504 | ) | | (260,529 | ) | | 1,579,042 | | | — | | | |
| |
Net cash used in investing activities | (196,068 | ) | | (62,287 | ) | | (289,077 | ) | | 518,884 | | | (28,548 | ) | | |
| |
| | | | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | |
Repayments of Senior Debt | (400,673 | ) | | — | | | (312,246 | ) | | — | | | (712,919 | ) | | |
| |
Debt transactions costs | (12,396 | ) | | — | | | (1,810 | ) | | — | | | (14,206 | ) | | |
| |
Issuance of Senior Debt | 550,421 | | | — | | | — | | | — | | | 550,421 | | | |
| |
Proceeds from credit facilities | 25,000 | | | — | | | — | | | — | | | 25,000 | | | |
| |
Payment of credit facilities and capital leases | — | | | — | | | (1,080 | ) | | — | | | (1,080 | ) | | |
| |
Issuance of common stock warrants | 191,825 | | | — | | | — | | | — | | | 191,825 | | | |
| |
Dividends paid to holders of noncontrolling interests | — | | | — | | | (46 | ) | | — | | | (46 | ) | | |
| |
Intercompany financing receipts | — | | | 634,862 | | | 720,248 | | | (1,355,110 | ) | | — | | | |
| |
Intercompany financing payments | (243,778 | ) | | (443,412 | ) | | (149,036 | ) | | 836,226 | | | — | | | |
| |
Net cash provided by financing activities | 110,399 | | | 191,450 | | | 256,030 | | | (518,884 | ) | | 38,995 | | | |
| |
| | | | | | | | | | | |
Net cash used in discontinued operations - operating activities | (350 | ) | | — | | | (1,058 | ) | | — | | | (1,408 | ) | | |
| |
Net cash used in discontinued operations - investing activities | — | | | — | | | (228 | ) | | — | | | (228 | ) | | |
| |
Net cash used in discontinued operations - financing activities | — | | | — | | | (942 | ) | | — | | | (942 | ) | | |
| |
| | | | | | | | | | | |
Impact of exchange rate fluctuations on cash | — | | | 916 | | | (11,567 | ) | | — | | | (10,651 | ) | | |
| |
| | | | | | | | | | | |
Net decrease in cash and cash equivalents | (18,848 | ) | | (2,491 | ) | | (46,685 | ) | | — | | | (68,024 | ) | | |
| |
CASH AND CASH EQUIVALENTS, beginning of period | 19,461 | | | 5,422 | | | 77,439 | | | — | | | 102,322 | | | |
| |
CASH AND CASH EQUIVALENTS, end of period | $ | 613 | | | $ | 2,931 | | | $ | 30,754 | | | $ | — | | | $ | 34,298 | | | |
| |
|
Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2013 |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | |
|
Net cash (used in) / generated from operating activities | $ | (80,304 | ) | | $ | 288,651 | | | $ | (269,417 | ) | | $ | — | | | $ | (61,070 | ) |
|
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | |
|
Purchase of property, plant and equipment | — | | | — | | | (30,118 | ) | | — | | | (30,118 | ) |
|
Disposal of property, plant and equipment | — | | | — | | | 283 | | | — | | | 283 | |
|
Intercompany investing receipts | 609,801 | | | 9,323 | | | — | | | (619,124 | ) | | — | |
|
Intercompany investing payments | (580,533 | ) | | (266,355 | ) | | — | | | 846,888 | | | — | |
|
Net cash used in investing activities | 29,268 | | | (257,032 | ) | | (29,835 | ) | | 227,764 | | | (29,835 | ) |
|
| | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | |
Repayments of Senior Debt | (310,322 | ) | | — | | | — | | | — | | | (310,322 | ) |
|
Debt transactions costs | (785 | ) | | — | | | — | | | — | | | (785 | ) |
|
Change in restricted cash | 20,467 | | | — | | | 138 | | | — | | | 20,605 | |
|
Proceeds from credit facilities | — | | | — | | | 40 | | | — | | | 40 | |
|
Payment of credit facilities and capital leases | — | | | — | | | (1,648 | ) | | — | | | (1,648 | ) |
|
Issuance of common stock | 157,116 | | | — | | | — | | | — | | | 157,116 | |
|
Issuance of preferred stock | 200,000 | | | — | | | — | | | — | | | 200,000 | |
|
Equity issuance costs | (5,410 | ) | | — | | | — | | | — | | | (5,410 | ) |
|
Proceeds from exercise of stock options | 59 | | | — | | | — | | | — | | | 59 | |
|
Dividends paid to holders of noncontrolling interests | — | | | — | | | (411 | ) | | — | | | (411 | ) |
|
Intercompany financing receipts | — | | | 580,533 | | — | | 266,355 | | — | | (846,888 | ) | | — | |
|
Intercompany financing payments | — | | | (609,801 | ) | — | | (9,323 | ) | — | | 619,124 | | | — | |
|
Net cash provided / (used in) by financing activities | 61,125 | | | (29,268 | ) | | 255,151 | | | (227,764 | ) | | 59,244 | |
|
| | | | | | | | | |
Net cash used in discontinued operations - operating activities | — | | | — | | | (1,952 | ) | | — | | | (1,952 | ) |
|
Net cash used in discontinued operations - investing activities | — | | | — | | | (301 | ) | | — | | | (301 | ) |
|
Net cash provided by discontinued operations - financing activities | — | | | — | | | 77 | | | — | | | 77 | |
|
| | | | | | | | | |
Impact of exchange rate fluctuations on cash | — | | | 235 | | | (619 | ) | | — | | | (384 | ) |
|
Net increase / (decrease) in cash and cash equivalents | 10,089 | | | 2,586 | | | (46,896 | ) | | — | | | (34,221 | ) |
|
CASH AND CASH EQUIVALENTS, beginning of period | 9,372 | | | 2,836 | | | 124,335 | | | — | | | 136,543 | |
|
CASH AND CASH EQUIVALENTS, end of period | $ | 19,461 | | | $ | 5,422 | | | $ | 77,439 | | | $ | — | | | $ | 102,322 | |
|
Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2012 |
| | | | | | | | | | | | | | | | | | | | | |
| Parent Issuer | | | Guarantor Subsidiaries | | | Non-Guarantor Subsidiaries | | | Eliminations | | | Consolidated | |
|
Net cash generated from / (used in) operating activities | $ | 5,223 | | | (31,744 | ) | | (1,149 | ) | | — | | | (27,670 | ) |
|
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | |
Purchase of property, plant and equipment | — | | | — | | | (31,327 | ) | | — | | | (31,327 | ) |
|
Disposal of property, plant and equipment | — | | | — | | | 236 | | | — | | | 236 | |
|
Intercompany investing payments | (321,212 | ) | | (303,558 | ) | | — | | | 624,770 | | | — | |
|
Intercompany investing receipts | 319,669 | | | 259,487 | | | — | | | (579,156 | ) | | — | |
|
Net cash used in investing activities | (1,543 | ) | | (44,071 | ) | | (31,091 | ) | | 45,614 | | | (31,091 | ) |
|
| | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | |
|
Repayments of Senior Debt | (290,135 | ) | | — | | | — | | | — | | | (290,135 | ) |
|
Debt transactions costs | (4,350 | ) | | — | | | (2,650 | ) | | — | | | (7,000 | ) |
|
Issuance of Senior Debt | 135,949 | | | — | | | 92,941 | | | — | | | 228,890 | |
|
Change in restricted cash | (20,972 | ) | | — | | | (10 | ) | | — | | | (20,982 | ) |
|
Proceeds from credit facilities | 180,179 | | | — | | | 11,080 | | | — | | | 191,259 | |
|
Payment of credit facilities and capital leases | (15,330 | ) | | — | | | (85,866 | ) | | — | | | (101,196 | ) |
|
Issuance of common stock | 15,033 | | | — | | | — | | | — | | | 15,033 | |
|
Equity issuance costs | (2,942 | ) | | — | | | — | | | — | | | (2,942 | ) |
|
Dividends paid to holders of noncontrolling interests | — | | | — | | | (308 | ) | | — | | | (308 | ) |
|
Intercompany financing receipts | — | | | 321,212 | | — | | 303,558 | | — | | (624,770 | ) | | — | |
|
Intercompany financing payments | — | | | (294,222 | ) | — | | (284,934 | ) | — | | 579,156 | | | — | |
|
Net cash (used in) / provided by financing activities | (2,568 | ) | | 26,990 | | | 33,811 | | | (45,614 | ) | | 12,619 | |
|
| | | | | | | | | |
Net cash used in discontinued operations - operating activities | — | | | — | | | (1,122 | ) | | — | | | (1,122 | ) |
|
Net cash used in discontinued operations - investing activities | — | | | — | | | (1,335 | ) | | — | | | (1,335 | ) |
|
Net cash used in discontinued operations - financing activities | — | | | — | | | (723 | ) | | — | | | (723 | ) |
|
| | | | | | | | | |
Impact of exchange rate fluctuations on cash | — | | | — | | | 4,564 | | | — | | | 4,564 | |
|
Net increase / (decrease) in cash and cash equivalents | 1,112 | | | (48,825 | ) | | 2,955 | | | — | | | (44,758 | ) |
|
CASH AND CASH EQUIVALENTS, beginning of period | 8,260 | | | 51,661 | | | 121,380 | | | — | | | 181,301 | |
|
CASH AND CASH EQUIVALENTS, end of period | $ | 9,372 | | | $ | 2,836 | | | $ | 124,335 | | | $ | — | | | $ | 136,543 | |
|
| | | | | | | | | | | | | | | | | | | | | | |